Related Experiment Video
Updated: Jul 30, 2026

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination
Published on: September 12, 2016
Immune network analysis of cerebrospinal fluid in myalgic encephalomyelitis/chronic fatigue syndrome with atypical
M Hornig1,2, C G Gottschalk3, M L Eddy1
1Center for Infection and Immunity, Columbia University Mailman School of Public Health, New York, NY, USA.
Abstract:
Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a persistent and debilitating disorder marked by cognitive and sensory dysfunction and unexplained physical fatigue. Classically, cases present after a prodrome consistent with infection; however, some cases are atypical and have a different presentation and comorbidities that pose challenges for differential diagnosis. We analyzed cerebrospinal fluid (CSF) from 32 cases with classical ME/CFS and 27 cases with atypical ME/CFS using a 51-plex cytokine assay. Atypical subjects differed in cytokine profiles from classical subjects. In logistic regression models incorporating immune molecules that were identified as potential predictor variables through feature selection, we found strong associations between the atypical ME/CFS phenotype and lower CSF levels of the inflammatory mediators, interleukin 17A and CXCL9. Network analysis revealed an absence of inverse inter-cytokine relationships in CSF from atypical patients, and more sparse positive intercorrelations, than classical subjects. Interleukin 1 receptor antagonist appeared to be a negative regulator in classical ME/CFS, with patterns suggestive of disturbances in interleukin 1 signaling and autoimmunity-type patterns of immune activation. Immune signatures in the central nervous system of ME/CFS patients with atypical features may be distinct from those with more typical clinical presentations.
Insights
Atypical Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) cases show distinct immune signatures in cerebrospinal fluid, differing from classical ME/CFS presentations. Lower levels of specific inflammatory mediators are associated with atypical ME/CFS phenotypes.
Area of Science:
- Neuroimmunology
- Infectious Disease Immunology
Background:
- Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a complex, debilitating illness characterized by fatigue, cognitive dysfunction, and sensory issues.
- While classical ME/CFS often follows an infection, atypical presentations with unique comorbidities complicate diagnosis and understanding.
- Investigating central nervous system immune markers is crucial for differentiating ME/CFS subtypes.
Purpose of the Study:
- To compare cerebrospinal fluid (CSF) cytokine profiles between classical and atypical ME/CFS cases.
- To identify immune molecules associated with the atypical ME/CFS phenotype.
- To explore differences in immune network interactions within the CSF of ME/CFS subtypes.
Main Methods:
- Analysis of CSF from 32 classical and 27 atypical ME/CFS patients using a 51-plex cytokine assay.
- Logistic regression modeling with feature selection to identify predictor variables.
- Network analysis to examine inter-cytokine relationships.
Main Results:
- Significant differences in CSF cytokine profiles were observed between classical and atypical ME/CFS groups.
- Lower CSF levels of interleukin-17A and CXCL9 were strongly associated with the atypical ME/CFS phenotype.
- Atypical ME/CFS patients lacked inverse inter-cytokine relationships and had sparser positive correlations compared to classical ME/CFS patients.
Conclusions:
- Immune signatures in the central nervous system may differ between classical and atypical ME/CFS presentations.
- Disturbances in interleukin-1 signaling and autoimmunity-like immune activation patterns were suggested in classical ME/CFS.
- These findings highlight distinct neuroinflammatory pathways in ME/CFS subtypes, aiding differential diagnosis.
More Related Videos
09:01Flow Cytometric Analysis of Lymphocyte Infiltration in Central Nervous System during Experimental Autoimmune Encephalomyelitis
Published on: November 17, 2020
08:49Simultaneous Isolation of Principal Central Nervous System-Resident Cell Types from Adult Autoimmune Encephalomyelitis Mice
Published on: October 6, 2023